» Articles » PMID: 15757802

Epidemiology and Natural History of Hepatocellular Carcinoma

Overview
Publisher Elsevier
Specialty Gastroenterology
Date 2005 Mar 11
PMID 15757802
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality. There is a wide variation, however, in the global distribution of HCC. Eighty percent of the burden is borne by countries in Asia and sub-Saharan Africa. In most high-risk countries, principal risk factors include infection with hepatitis B virus and dietary exposure to aflatoxin B(1). In contrast, hepatitis C virus and alcohol consumption are more important risk factors in low-risk countries. In recent years, the incidence of HCC has decreased in some high-risk countries and increased in some low-risk countries. Reasons for both trends are not completely understood, but are likely related to public health efforts in Asia and the increase in hepatitis C virus infection in low-risk countries. Vaccination programs against hepatitis B virus will likely decrease the HCC rate even further in decades to come.

Citing Articles

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Ding T, Liu C, Li Z Mol Cancer. 2025; 24(1):18.

PMID: 39815314 PMC: 11734361. DOI: 10.1186/s12943-025-02227-8.


Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.

Ma Y, Gong Y, Qiu Q, Ma C, Yu S BMC Cancer. 2024; 24(1):363.

PMID: 38515051 PMC: 10956394. DOI: 10.1186/s12885-024-12109-9.


ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules.

Orabi M, Abouelela M, Darwish F, Abdelkader M, Elsadek B, Abdullah Al Awadh A Front Pharmacol. 2024; 15:1337910.

PMID: 38370475 PMC: 10871037. DOI: 10.3389/fphar.2024.1337910.


Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.

Barupal D, Ramos M, Florio A, Wheeler W, Weinstein S, Albanes D Int J Cancer. 2023; 154(3):454-464.

PMID: 37694774 PMC: 10845132. DOI: 10.1002/ijc.34726.


Low host immune pressure may be associated with the development of hepatocellular carcinoma: a longitudinal analysis of complete genomes of the HBV 1762T, 1764A mutant.

Jiang Z, Chen Q, Jia H, Wang X, Zhang L, Huang X Front Oncol. 2023; 13:1214423.

PMID: 37681020 PMC: 10481955. DOI: 10.3389/fonc.2023.1214423.